264 related articles for article (PubMed ID: 34637800)
1. Curcuma as an adjuvant in colorectal cancer treatment.
Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
[TBL] [Abstract][Full Text] [Related]
2. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
5. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
[TBL] [Abstract][Full Text] [Related]
6. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells.
Ghasemi F; Shafiee M; Banikazemi Z; Pourhanifeh MH; Khanbabaei H; Shamshirian A; Amiri Moghadam S; ArefNezhad R; Sahebkar A; Avan A; Mirzaei H
Pathol Res Pract; 2019 Oct; 215(10):152556. PubMed ID: 31358480
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.
Johnson SM; Gulhati P; Arrieta I; Wang X; Uchida T; Gao T; Evers BM
Anticancer Res; 2009 Aug; 29(8):3185-90. PubMed ID: 19661333
[TBL] [Abstract][Full Text] [Related]
9. Evidence That Calebin A, a Component of
Buhrmann C; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31805741
[TBL] [Abstract][Full Text] [Related]
10. Curcumin - A Novel Therapeutic Agent in the Prevention of Colorectal Cancer.
Gupta MK; Vadde R; Sarojamma V
Curr Drug Metab; 2019; 20(12):977-987. PubMed ID: 31589120
[TBL] [Abstract][Full Text] [Related]
11. Curcumin, calebin A and chemosensitization: How are they linked to colorectal cancer?
Brockmueller A; Samuel SM; Mazurakova A; Büsselberg D; Kubatka P; Shakibaei M
Life Sci; 2023 Apr; 318():121504. PubMed ID: 36813082
[TBL] [Abstract][Full Text] [Related]
12. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
Ruiz de Porras V; Bystrup S; Martínez-Cardús A; Pluvinet R; Sumoy L; Howells L; James MI; Iwuji C; Manzano JL; Layos L; Bugés C; Abad A; Martínez-Balibrea E
Sci Rep; 2016 Apr; 6():24675. PubMed ID: 27091625
[TBL] [Abstract][Full Text] [Related]
13. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo.
Li M; Yue GG; Tsui SK; Fung KP; Lau CB
Phytomedicine; 2018 Jul; 46():131-141. PubMed ID: 30097113
[TBL] [Abstract][Full Text] [Related]
14. Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity.
Joshi P; Joshi S; Semwal D; Bisht A; Paliwal S; Dwivedi J; Sharma S
Mini Rev Med Chem; 2021; 21(17):2420-2457. PubMed ID: 33480345
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits high glucose‑induced inflammatory injury in human retinal pigment epithelial cells through the ROS‑PI3K/AKT/mTOR signaling pathway.
Ran Z; Zhang Y; Wen X; Ma J
Mol Med Rep; 2019 Feb; 19(2):1024-1031. PubMed ID: 30569107
[TBL] [Abstract][Full Text] [Related]
16. Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro.
Chen MB; Wu XY; Tao GQ; Liu CY; Chen J; Wang LQ; Lu PH
Int J Cancer; 2012 Dec; 131(11):2487-98. PubMed ID: 22438101
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits the formation of atherosclerosis in ApoE
Lv YL; Jia Y; Wan Z; An ZL; Yang S; Han FF; Gong LL; Xuan LL; Ren LL; Zhang W; Liu H; Liu LH
Life Sci; 2020 Sep; 257():117658. PubMed ID: 32621921
[TBL] [Abstract][Full Text] [Related]
18. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review.
Memarzia A; Khazdair MR; Behrouz S; Gholamnezhad Z; Jafarnezhad M; Saadat S; Boskabady MH
Biofactors; 2021 May; 47(3):311-350. PubMed ID: 33606322
[TBL] [Abstract][Full Text] [Related]
19. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
[TBL] [Abstract][Full Text] [Related]
20. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
